Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.

ABSTRACT:

SUBMITTER: Trefond L 

PROVIDER: S-EPMC8152361 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature